tests and whether these tests will be for drugs, alcohol, or both, unless otherwise directed by the appropriate DOT agency regulation. For example, if the employee had a positive drug test, but your evalua- tion or the treatment program profession- als determined that the employee had an alcohol problem as well, you should require that the employee have follow-up tests for both drugs and alcohol. 49 CFR Part 40.307(c) (3) You [as the
SAP] are not to establish the actual dates for the follow-up tests you prescribe. Te decision on specific dates to test is the employer’s.
QUESTION: What exactly is an IITF used for?
ANSWER: An IITF (Instrumental Initial Test Facility) is used to conduct initial
drug testing. However, if the initial test indicates a non-negative drug screen, then the sample must be sent to a certified lab to do the confirmation testing. IITFs are approved for HHS drug testing, but not for DOT drug testing.
QUESTION: If a donor arrives at a collec- tion facility for a DOT drug test and she makes an unsuccessful atempt to provide a sample (and therefore enters into a shy bladder situation) what should I, as the collector, do if aſter two hours the donor provides a specimen that is out of tempera- ture range?
ANSWER: You should package the initial specimen for shipping and then instruct the donor that she now has to provide a specimen under direct observation within the next one hour.
QUESTION: Do collectors sign the CCF in situations in which a urine specimen is not provided during a collection (i.e., a refusal to provide a specimen; a shy bladder situation)?
ANSWER: • In any such case, the collector would check the box in Step 2 of the CCF indicating that no specimen was provided and enter an explanatory remark.
• Te collector would then provide his or her name and signature in Step 4 of the CCF.
• Te employee’s name and phone number should be included on the MRO copy.
• Te collector would then transmit the CCF copies to the appropriate parties (e.g., employer, MRO). ❚
www.datia.org
datia focus
37
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46